6,236 Shares in Danaher Corporation $DHR Purchased by Bluedoor Private Wealth LLC

Bluedoor Private Wealth LLC acquired a new position in shares of Danaher Corporation (NYSE:DHRFree Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,236 shares of the conglomerate’s stock, valued at approximately $1,428,000.

A number of other large investors have also added to or reduced their stakes in the stock. State Street Corp increased its holdings in Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after buying an additional 472,608 shares during the last quarter. Capital International Investors increased its holdings in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares during the last quarter. Norges Bank purchased a new stake in Danaher during the fourth quarter worth about $2,177,106,000. Generation Investment Management LLP increased its holdings in Danaher by 14.1% during the fourth quarter. Generation Investment Management LLP now owns 7,589,661 shares of the conglomerate’s stock worth $1,737,425,000 after buying an additional 934,995 shares during the last quarter. Finally, Franklin Resources Inc. increased its stake in shares of Danaher by 14.9% in the fourth quarter. Franklin Resources Inc. now owns 4,931,303 shares of the conglomerate’s stock worth $1,128,874,000 after purchasing an additional 637,666 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $181.04 on Tuesday. The firm has a 50 day moving average of $180.73 and a 200-day moving average of $204.27. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market capitalization of $128.13 billion, a P/E ratio of 35.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period last year, the business earned $1.88 earnings per share. Danaher’s revenue was up 3.7% compared to the same quarter last year. As a group, sell-side analysts predict that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on DHR. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Argus reduced their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Royal Bank Of Canada began coverage on shares of Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price for the company. HSBC reduced their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Morgan Stanley reduced their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Check Out Our Latest Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.